By encouraging the oxidation of sarcomeric protein and facilitating cardiac inflammation and apoptosis, MPO, a marker of inflammation, was reported to be elevated in patients with heart failure and cardiac dysfunction (Reichlin et al. 2010; Nettersheim et al. 2023). Here, MPO is linked to heart failure.